Bellingham James, Davidson Alice E, Aboshiha Jonathan, Simonelli Francesca, Bainbridge James W, Michaelides Michel, van der Spuy Jacqueline
UCL Institute of Ophthalmology London, United Kingdom.
UCL Institute of Ophthalmology London, United Kingdom 2Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Invest Ophthalmol Vis Sci. 2015 Dec 1;56(13):7784-7793. doi: 10.1167/iovs.15-18092.
Biallelic mutations in AIPL1 cause Leber congenital amaurosis (LCA), a devastating retinal degeneration characterized by the loss or severe impairment of vision within the first few years of life. AIPL1 is highly polymorphic with more than 50 mutations and many more polymorphisms of uncertain pathogenicity identified. As such, it can be difficult to assign disease association of AIPL1 variations. In this study, we investigate suspected disease-associated AIPL1 variations, including nonsynonymous missense and intronic variants to validate their pathogenicity.
AIPL1 minigenes harboring missense and intronic variations were constructed by amplification of genomic fragments of the human AIPL1 gene. In vitro splice assays were performed to identify the resultant AIPL1 transcripts.
We show that all nine of the suspected disease-associated AIPL1 variations investigated induced aberrant pre-mRNA splicing of the AIPL1 gene, and our study is the first to show that AIPL1 missense mutations alter AIPL1 splicing. We reveal that the presumed rare benign variant c.784G>A [p.(G262S)] alters in vitro AIPL1 splicing, thereby validating the disease-association and clarifying the underlying disease mechanism. We also reveal that in-phase exon skipping occurs normally at a low frequency in the retina, but arises abundantly as a consequence of specific AIPL1 variations, suggesting a tolerance threshold for the expression of these alternative transcripts in the retina normally, which is exceeded in LCA.
Our data confirm the disease-association of the AIPL1 variations investigated and reveal for the first time that aberrant splicing of AIPL1 is an underlying mechanism of disease in LCA.
AIPL1基因的双等位基因突变会导致莱伯先天性黑蒙(LCA),这是一种严重的视网膜变性疾病,其特征是在生命的最初几年内视力丧失或严重受损。AIPL1具有高度多态性,已鉴定出50多种突变以及更多致病性不确定的多态性。因此,很难确定AIPL1变异与疾病的关联。在本研究中,我们调查了疑似与疾病相关的AIPL1变异,包括非同义错义变异和内含子变异,以验证它们的致病性。
通过扩增人类AIPL1基因的基因组片段构建携带错义变异和内含子变异的AIPL1小基因。进行体外剪接试验以鉴定产生的AIPL1转录本。
我们发现,所研究的所有9种疑似与疾病相关的AIPL1变异均诱导了AIPL1基因异常的前体mRNA剪接,并且我们的研究首次表明AIPL1错义突变会改变AIPL1剪接。我们发现推测的罕见良性变异c.784G>A [p.(G262S)]会改变体外AIPL1剪接过程,从而验证了其与疾病的关联并阐明了潜在的疾病机制。我们还发现,同相位外显子跳跃在视网膜中通常以低频率正常发生,但由于特定的AIPL1变异而大量出现,这表明视网膜中这些替代转录本的表达通常存在一个耐受阈值,而在LCA中该阈值被超过。
我们的数据证实了所研究的AIPL1变异与疾病的关联,并首次揭示AIPL1的异常剪接是LCA疾病发生的潜在机制。